Lung Diseases

ERT Expands Respiratory Solutions to Support New Endpoints

February 8, 2018

ERT Expands Respiratory Solutions to Support New Endpoints Industry-leading MasterScope™ integration provides centralized Forced Oscillation Technique services to deliver high quality data while lessening patient and site burden PHILADELPHIA – February 8, 2018 – ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced advanced respiratory clinical trial […]

Asthma & COPD

November 27, 2017

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

Asana BioSciences to Present Updates on its Oncology Development Pipeline at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 25, 2017

Asana BioSciences, LLC, an oncology focused, clinical stage biopharmaceutical company, today announced that it will present updates regarding three of its lead molecules at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Philadelphia, PA, October 26-30, 2017. “We are very pleased with the progress made in advancing our oncology […]

Mesothelioma Victims Center Offers a New Tip for Navy Veterans with Mesothelioma That Ensures They Hire the Most Skilled Attorneys Because-The Best Possible Compensation Depends on It

June 29, 2017

NEW YORK, June 29, 2017 /PRNewswire/ — The Mesothelioma Victims Center is the top-branded resource on the Internet for ‘The best mesothelioma compensation for a US Navy Veteran’ who has this rare form of cancer caused by exposure to asbestos. The reason the group has placed such a large emphasis on Navy Veterans and mesothelioma […]

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

June 1, 2017

DURHAM, N.C., May 30, 2017 (GLOBE NEWSWIRE) — GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the appointments of Walter M. Capone as Chief Business Officer and Ellen Lubman to the company’s Board of Directors.  In his role as CBO, Mr. Capone […]

ERT Introduces Advanced Solution to Capture, Measure and Analyze Lung Clearance Index (LCI)

May 24, 2017

ERT Introduces Advanced Solution to Capture, Measure and Analyze Lung Clearance Index (LCI) Solution provides greater data granularity to measure disease progression in respiratory trials where standard spirometry is insufficient PHILADELPHIA – May 22, 2017 – ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced […]

New Approach Uses Ultrasound to Measure Fluid in the Lungs

March 22, 2017

FOR IMMEDIATE RELEASE A team of engineering and medical researchers has found a way to use ultrasound to monitor fluid levels in the lung, offering a noninvasive way to track progress in treating pulmonary edema – fluid in the lungs – which often occurs in patients with congestive heart failure. The approach, which has been […]

The 5 most common mistakes in Spirometry collection

October 25, 2016

Spirometry data is pivotal to assessing primary or secondary outcomes in most respiratory trials. A significant portion of spirometry data is of inadequate or questionable quality which can lead to increased data variability, undermine the validity of the results of a trial, and necessitate increasing the number of subjects in a trial. View the infographic now […]

FEEDBACK